ONIT Study

Sean Mulqueeny, OD
EyePromise EZ Tears

Advances in Ophthalmology & Visual System 

The ONIT Study–Ocular Nutrition Impact on Tear 



Volume 2 Issue 2 – 2015 Sean P Mulqueeny1*, Robert L Davis2, William D Townsend3 and Bruce H Koffler4 Mulqueeny Eye Centers, USA *Corresponding author: Sean P Mulqueeny, Mulqueeny Eye Centers, 612 N New Ballas Road, Saint Louis, MO 63141, Tel: 314-542-3600; Email: Received: January 27, 2015 | Published: March 26, 2015


Purpose: To better understand the role of a proprietary dietary supplement formulated to contain Omega 3 and seven other anti-inflammatories plays in patients with established clinical findings consistent with dry eye disease. Secondarily, this evaluation will attempt to discover if any of the diagnostic markers are predictive to the therapeutic approach of omega 3 anti- inflammatory dietary supplements.

Design: Clinic-based, multi-center cohort study.

Methods: This eight-week feasibility study was to determine if subjects presenting with dry eye confirmed by diagnostic markers and symptoms responded to nutritional therapy via an oral nutritional supplement (EyePromise EZ Tears). Analyses were completed on a subgroup of subjects with 4 of 7 possible diagnostic criteria.

Results: A total of 67 patients were enrolled between 18-79 years of age inclusive. At the conclusion of the study, improvement from baseline was demonstrated in OSDI decreasing scores by 38%. Improved tear breakup time and phenol red thread scores were seen and was reduced conjunctival staining. There was also a decrease noted in lid inflammation. Osmolarity scores were variable and inconclusive.  

Conclusion: Supplementation with this Omega-3 anti-inflammatory product in dry eye showed significant improvement in OSDI, TBUT, conjunctival staining, lid inflammation, and phenol red thread, tear meniscus, and corneal staining scores. This decrease in patient symptoms could be an indication of decreasing ocular surface inflammation and possible stabilization of the lipid layer. The change from baseline for these signs appears to be rapid, as differences were shown as early as one-week post-supplementation.

ONIT Clinical Research Study – AOVS-02-00038

Download the PDF by clicking the link below: 

ONIT Clinical Research Study – AOVS-02-00038



EyePromise EZ Tears™
Dry Eye and Contact Lens Comfort Formula 

EyePromise EZ Tears was used as the ocular nutritional supplement for the Ocular Nutrition Impact on Tear Film Study (ONIT).  Here a few reasons why EyePromise EZ  Tears is quickly becoming the dry eye supplement of choice for many leading Optometrists and Ophthalmologists: 

  • Rapid onset of action – in as little as one week 
  • 30-Day Dry Eye Relief Guarantee
  • Nine essential ingredients for healthy tear film 
  • Comprehensive training for you and your staff
  • Ongoing marketing support for promoting dry eye in your practice 
  • And much more…

 Click here to learn more about EyePromise EZ Tears 

Set-up a Free Dry Eye Consultation!